Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Apr;27(4):646–647. doi: 10.1128/aac.27.4.646

In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.

S Alvarez, M Jones, S Holtsclaw-Berk, J Guarderas, S L Berk
PMCID: PMC180113  PMID: 3873905

Abstract

We tested 53 clinical isolates of Branhamella catarrhalis recovered from patients with respiratory symptoms to determine the susceptibility of the isolates to 25 antimicrobial agents, including the newer beta-lactam antibiotics. Of the 53 strains, 46 (86.7%) were beta-lactamase producers. All the strains were susceptible to the majority of the new penicillins and cephalosporins. The combinations of amoxacillin-clavulanic acid and ticarcillin-clavulanic acid were also very active against the beta-lactamase-producing strains.

Full text

PDF
646

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brorson J. E., Axelsson A., Holm S. E. Studies on Branhamella Catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand J Infect Dis. 1976;8(3):151–155. doi: 10.3109/inf.1976.8.issue-3.05. [DOI] [PubMed] [Google Scholar]
  2. Diamond L. A., Lorber B. Branhamella catarrhalis pneumonia and immunoglobulin abnormalities: a new association. Am Rev Respir Dis. 1984 May;129(5):876–878. doi: 10.1164/arrd.1984.129.5.876. [DOI] [PubMed] [Google Scholar]
  3. Doern G. V., Miller M. J., Winn R. E. Branhamella (Neisseria) catarrhalis systemic disease in humans. Case reports and review of the literature. Arch Intern Med. 1981 Nov;141(12):1690–1692. [PubMed] [Google Scholar]
  4. Doern G. V., Morse S. A. Branhamella (Neisseria) catarrhalis: criteria for laboratory identification. J Clin Microbiol. 1980 Feb;11(2):193–195. doi: 10.1128/jcm.11.2.193-195.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Doern G. V., Siebers K. G., Hallick L. M., Morse S. A. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis. Antimicrob Agents Chemother. 1980 Jan;17(1):24–29. doi: 10.1128/aac.17.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Douer D., Danziger Y., Pinkhas J. Neisseria catarrhalis endocarditis. Ann Intern Med. 1977 Jan;86(1):116–116. doi: 10.7326/0003-4819-86-1-116_1. [DOI] [PubMed] [Google Scholar]
  7. Johnson M. A., Drew W. L., Roberts M. Branhamella (Neisseria) catarrhalis--a lower respiratory tract pathogen? J Clin Microbiol. 1981 Jun;13(6):1066–1069. doi: 10.1128/jcm.13.6.1066-1069.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kallings I., Bengtsson S., Christensen P., Holm S. E., Lind L., Kalin M. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scand J Infect Dis Suppl. 1983;39:100–105. [PubMed] [Google Scholar]
  9. Kovatch A. L., Wald E. R., Michaels R. H. beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children. J Pediatr. 1983 Feb;102(2):261–264. doi: 10.1016/s0022-3476(83)80537-x. [DOI] [PubMed] [Google Scholar]
  10. Louie M. H., Gabay E. L., Mathisen G. E., Finegold S. M. Branhamella catarrhalis pneumonia. West J Med. 1983 Jan;138(1):47–49. [PMC free article] [PubMed] [Google Scholar]
  11. Ninane G., Joly J., Kraytman M. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. Br Med J. 1978 Feb 4;1(6108):276–278. doi: 10.1136/bmj.1.6108.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. PFISTER L. E., GALLAGHER M. V., POTTERFIELD T. G., BROWN D. W. NEISSERIA CATARRHALIS BACTEREMIA WITH MENINGITIS. JAMA. 1965 Aug 2;193:399–401. doi: 10.1001/jama.1965.03090050075029. [DOI] [PubMed] [Google Scholar]
  13. Pollock A. A., Holzman R. S. Letter: Neisseria catarrhalis endocarditis. Ann Intern Med. 1976 Aug;85(2):206–207. doi: 10.7326/0003-4819-85-2-206. [DOI] [PubMed] [Google Scholar]
  14. Schalén L., Christensen P., Kamme C., Miörner H., Pettersson K. I., Schalén C. High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis. Scand J Infect Dis. 1980;12(4):277–280. doi: 10.3109/inf.1980.12.issue-4.07. [DOI] [PubMed] [Google Scholar]
  15. Slevin N. J., Aitken J., Thornley P. E. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections. Lancet. 1984 Apr 7;1(8380):782–783. doi: 10.1016/s0140-6736(84)91288-1. [DOI] [PubMed] [Google Scholar]
  16. West M., Berk S. L., Smith J. K. Branhamella catarrhalis pneumonia. South Med J. 1982 Aug;75(8):1021–1023. doi: 10.1097/00007611-198208000-00029. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES